The tRCC cases were classified into three subtypes, GP1, GP2, and GP3 comprising 29, 26, and 19 cases, respectively (Fig. 6a, Supplementary Fig. 6a–c). This evidence concerns the gene GP2 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.